|
|
|
|
 |
|||
|
|||
Ultrastructural localization of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) to the abluminal plasma membrane and vesiculovacuolar organelles of tumor microvascular endothelium
, JA Nagy, DR Senger, HF Dvorak and AM Dvorak
Department of Pathology, Beth Israel Hospital, Boston, MA 02215.
Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) is a cytokine secreted by many animal and human tumors, activated macrophages, keratinocytes, rheumatoid synovial cells, embryonic tissues, and by cultured epithelial and mesenchymal cell lines. It acts selectively on vascular endothelial cells to increase their permeability to circulating macromolecules and to stimulate their replication. Although not detectably expressed by vascular cells in the human and animal tumors we have studied, VPF/VEGF accumulates in the microvessels supplying tumors and certain inflammatory reactions in which VPF/VEGF is also overexpressed. Light microscopic immunohistochemistry lacked the resolution necessary to localize VPF/VEGF precisely in such vessels. Therefore, we used a pre-embedding immunocytochemical method to localize VPF/VEGF at the ultrastructural level in the new blood vessels that are elicited in the peritoneal walls of mice bearing a transplantable mouse ascites tumor of ovarian origin. Intense immunostaining for VPF/VEGF was observed on the abluminal plasma membrane of tumor-associated microvascular endothelial cells and in vesiculovacuolar organelles (VVOs) present in these same endothelial cells. (VVOs are recently described cytoplasmic organelles present in tumor vascular endothelium that provide an important pathway for extravasation of circulating macromolecules.) In contrast to labeling of the abluminal plasma membrane and VVO vesicles and vacuoles, endothelial cytoplasmic organelles, such as multivesicular bodies and Weibel-Palade bodies, and the underlying basal lamina, did not stain with antibodies to VPF/VEGF. The distribution of VPF/VEGF here described corresponds to that anticipated for high-affinity VFP/VEGF receptors, although binding of VPF/VEGF to other endothelial cell surface structures, such as plasma membrane proteoglycans, is also a possibility.
Volume 43,
Issue 4,
pp. 381-389,
04/01/1995
Copyright © 1995 by The Histochemical Society
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  M. M. Fuster, L. Wang, J. Castagnola, L. Sikora, K. Reddi, P. H.A. Lee, K. A. Radek, M. Schuksz, J. R. Bishop, R. L. Gallo, et al. Genetic alteration of endothelial heparan sulfate selectively inhibits tumor angiogenesis J. Cell Biol., May 7, 2007; 177(3): 539 - 549. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. M. Fu and S. Shen Structural mechanisms of acute VEGF effect on microvessel permeability Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2124 - H2135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. F. Dvorak Vascular Permeability Factor/Vascular Endothelial Growth Factor: A Critical Cytokine in Tumor Angiogenesis and a Potential Target for Diagnosis and Therapy J. Clin. Oncol., November 1, 2002; 20(21): 4368 - 4380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. N. Witmer, J. Dai, H. A. Weich, G. F.J.M. Vrensen, and R. O. Schlingemann Expression of Vascular Endothelial Growth Factor Receptors 1, 2, and 3 in Quiescent Endothelia J. Histochem. Cytochem., June 1, 2002; 50(6): 767 - 778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Bocci, A. Fasciani, R. Danesi, P. Viacava, A. R. Genazzani, and M. D. Tacca In-vitro evidence of autocrine secretion of vascular endothelial growth factor by endothelial cells from human placental blood vessels Mol. Hum. Reprod., August 1, 2001; 7(8): 771 - 777. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Dvorak and D. Feng The Vesiculo-Vacuolar Organelle (VVO): A New Endothelial Cell Permeability Organelle J. Histochem. Cytochem., April 1, 2001; 49(4): 419 - 432. [Abstract] [Full Text]
|
|
|
|
 |
|
 I. Zachary and G. Gliki Signaling transduction mechanisms mediating biological actions of the vascular endothelial growth factor family Cardiovasc Res, February 16, 2001; 49(3): 568 - 581. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. L. Monsky, D. Fukumura, T. Gohongi, M. Ancukiewcz, H. A. Weich, V. P. Torchilin, F. Yuan, and R. K. Jain Augmentation of Transvascular Transport of Macromolecules and Nanoparticles in Tumors Using Vascular Endothelial Growth Factor Cancer Res., August 1, 1999; 59(16): 4129 - 4135. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Vasile, Qu-Hong, H. F. Dvorak, and A. M. Dvorak Caveolae and Vesiculo–Vacuolar Organelles in Bovine Capillary Endothelial Cells Cultured with VPF/VEGF on Floating Matrigel–collagen Gels J. Histochem. Cytochem., February 1, 1999; 47(2): 159 - 168. [Abstract] [Full Text]
|
|
|
|
|
|
G. Seghezzi, S. Patel, C. J. Ren, A. Gualandris, G. Pintucci, E. S. Robbins, R. L. Shapiro, A. C. Galloway, D. B. Rifkin, and P. Mignatti Fibroblast Growth Factor-2 (FGF-2) Induces Vascular Endothelial Growth Factor (VEGF) Expression in the Endothelial Cells of Forming Capillaries: An Autocrine Mechanism Contributing to Angiogenesis J. Cell Biol., June 29, 1998; 141(7): 1659 - 1673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Esser, K. Wolburg, H. Wolburg, G. Breier, T. Kurzchalia, and W. Risau Vascular Endothelial Growth Factor Induces Endothelial Fenestrations In Vitro J. Cell Biol., February 23, 1998; 140(4): 947 - 959. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Ferrara and T. Davis-Smyth The Biology of Vascular Endothelial Growth Factor Endocr. Rev., February 1, 1997; 18(1): 4 - 25. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. Patan, S. Tanda, S. Roberge, R. C. Jones, R. K. Jain, and L. L. Munn Vascular Morphogenesis and Remodeling in a Human Tumor Xenograft: Blood Vessel Formation and Growth After Ovariectomy and Tumor Implantation Circ. Res., October 12, 2001; 89(8): 732 - 739. [Abstract] [Full Text] [PDF]
|
|
| Guidelines | Subscriptions | About | exPRESS - Current - Archive | Business Information | Contact |